Synlait Milk : Update on Grass Fed™ infant formula U.S. launch

SYNLAIT MILK LIMITED ANNOUNCEMENT

14 AUGUST 2017

UPDATE ON GRA SS FED™ I NFANT FOR MULA U.S. LA UNCH

NZX: SML ASX: SMl

Synlait (NZX: SML; ASX: SM1) and Munch.kin are continuing to work through the U.S. Food and Drug Administration (FDA) registration process required to launch Grass Fed™ infant formula in the U.S.

Synlait and Munchkin understand the FDA process is expected ta take a further four to twelve months.

The stringent process, known as a New Infant Formula Notification (NIFN), includes a range of trials, audits and documentation.

"The FDA's NIFN process is thorough and requires time for comprehensive review. We remain confident Munchkin's Grass Fed™ infant formula will be launched inthe near future, however the timing of the launch will be slightly later than we've initially signalled, " said Jahn Penna, Synlait's Managing Director and CEO.

Mr Penna added the new timing will not have a material impact on Synlait's forecast FY18 volumes.

The U.S. launch also has no impact on the strength of Munchkin's Grass Fed™ infant formula, which continues ta steadily gain increased distribution in Australia and New Zealand.

Once launched, Grass Fed™ is poised to became only the second imported infant formula brand with U.S. FDA registration.

ENDS

For more information about Synlait, visit or www.synlait.com or contact: Dan Walraven

Communications Manager ,Synlait Milk

P: [phone]

E:[e-mail]

Synlait MilkLtd

1028Heslerton Road

RD13. Rakaia7783

Private Bag806

Ashburton7740

NewZealand

P [phone]

www.synlait.com Page 1of 1